Barbara de Graaff

1.5k total citations · 1 hit paper
63 papers, 997 citations indexed

About

Barbara de Graaff is a scholar working on Epidemiology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Barbara de Graaff has authored 63 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in General Health Professions and 15 papers in Economics and Econometrics. Recurrent topics in Barbara de Graaff's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Occupational and environmental lung diseases (8 papers). Barbara de Graaff is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Occupational and environmental lung diseases (8 papers). Barbara de Graaff collaborates with scholars based in Australia, United States and Vietnam. Barbara de Graaff's co-authors include Andrew Palmer, Lei Si, Christine E. McLaren, Olivier Loréal, Antonello Pietrangelo, Pierre Brissot, Paul C. Adams, Julie A. Campbell, Tania Winzenberg and Hasnat Ahmad and has published in prestigious journals such as PLoS ONE, Social Science & Medicine and Nature Reviews Disease Primers.

In The Last Decade

Barbara de Graaff

59 papers receiving 981 citations

Hit Papers

align trajectories

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara de Graaff Australia	16	209	174	171	171	156	63	997
Julie Krop United States	13	174 0.8×	163 0.9×	121 0.7×	63 0.4×	60 0.4×	33	1.2k
Araceli García-González United States	15	181 0.9×	106 0.6×	159 0.9×	108 0.6×	30 0.2×	45	1.0k
Donald A. Molony United States	20	173 0.8×	70 0.4×	52 0.3×	269 1.6×	142 0.9×	59	1.7k
Ashish Awasthi India	18	63 0.3×	177 1.0×	113 0.7×	62 0.4×	166 1.1×	53	1.1k
George C. Cunningham United States	17	160 0.8×	115 0.7×	182 1.1×	157 0.9×	131 0.8×	41	2.1k
David Collister Canada	18	117 0.6×	82 0.5×	97 0.6×	195 1.1×	24 0.2×	83	1.1k
Rebecca Birch United Kingdom	19	163 0.8×	126 0.7×	107 0.6×	104 0.6×	19 0.1×	68	1.2k
Svenja Seide Germany	15	96 0.5×	94 0.5×	68 0.4×	178 1.0×	37 0.2×	34	862
Soheir Adam United States	17	343 1.6×	120 0.7×	334 2.0×	125 0.7×	18 0.1×	56	1.4k
Gus Dekker Australia	29	191 0.9×	247 1.4×	36 0.2×	172 1.0×	119 0.8×	66	3.8k

Countries citing papers authored by Barbara de Graaff

Since Specialization

Citations

This map shows the geographic impact of Barbara de Graaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara de Graaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara de Graaff more than expected).

Fields of papers citing papers by Barbara de Graaff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara de Graaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara de Graaff. The network helps show where Barbara de Graaff may publish in the future.

Co-authorship network of co-authors of Barbara de Graaff

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara de Graaff. A scholar is included among the top collaborators of Barbara de Graaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara de Graaff. Barbara de Graaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Worthington, Joachim, Eleonora Feletto, Emily He, et al.. (2025). Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations. Medical Decision Making. 45(5). 569–586.

2.

Worthington, Joachim, Emily He, Michael Caruana, et al.. (2025). A Health Economic Evaluation of Routine Hepatocellular Carcinoma Surveillance for People with Compensated Cirrhosis to Support Australian Clinical Guidelines. MDM Policy & Practice. 10(1). 128091714–128091714.

3.

Zhao, Ting, et al.. (2024). The economic burden of long COVID in Australia: more noise than signal?. The Medical Journal of Australia. 221(S9). S31–S39. 1 indexed citations

4.

Zheng, Qiang, Lucy Leigh, Barbara de Graaff, et al.. (2023). Long‐term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia. Respirology. 28(10). 916–924. 13 indexed citations

5.

Nguyen, Anh Tuan, et al.. (2023). Surveillance for liver cancer in primary care: A systematic review of the evidence. Australian Journal of General Practice. 52(11). 801–807. 1 indexed citations

6.

Nguyen, Anh Tuan, Lei Si, John Lubel, et al.. (2023). Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling study. BMC Health Services Research. 23(1). 378–378. 4 indexed citations

7.

Cai, Guoqi, Graeme Jones, Flavia Cicuttini, et al.. (2022). Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS). Trials. 23(1). 768–768. 8 indexed citations

8.

Zheng, Qiang, Barbara de Graaff, Julie A. Campbell, et al.. (2022). The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. Quality of Life Research. 32(6). 1609–1619. 3 indexed citations

9.

Palmer, Andrew, Julie A. Campbell, Barbara de Graaff, et al.. (2021). Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia. Health Economics. 30(8). 1950–1977. 15 indexed citations

10.

Graaff, Barbara de, Julie A. Campbell, Petr Otáhal, et al.. (2021). The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia. Quality of Life Research. 30(9). 2615–2632. 6 indexed citations

11.

Zhao, Ting, Tania Winzenberg, Dawn Aitken, et al.. (2021). The impact of comorbidities on health-related quality of life of people with osteoarthritis over 10 years. Lara D. Veeken. 61(1). 139–145. 5 indexed citations

12.

Zhao, Ting, Hasnat Ahmad, Tania Winzenberg, et al.. (2020). Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study. Lara D. Veeken. 60(7). 3352–3359. 7 indexed citations

13.

Lartey, Stella T., Lei Si, Thomas Lung, et al.. (2020). Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana. BMJ Global Health. 5(9). e003332–e003332. 14 indexed citations

14.

Gardiner, F, et al.. (2020). Mental Health Crises in Rural and Remote Australia: An Assessment of Direct Medical Costs of Air Medical Retrievals and the Implications for the Societal Burden. Air Medical Journal. 39(5). 343–350. 8 indexed citations

15.

Arriagada, Nicolás Borchers, Barbara de Graaff, Tamera J. Corte, et al.. (2020). Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. European Respiratory Review. 29(158). 200154–200154. 37 indexed citations

16.

Lartey, Stella T., Costan G. Magnussen, Lei Si, et al.. (2019). The role of intergenerational educational mobility and household wealth in adult obesity: Evidence from Wave 2 of the World Health Organization’s Study on global AGEing and adult health. PLoS ONE. 14(1). e0208491–e0208491. 18 indexed citations

17.

Graaff, Barbara de, et al.. (2018). Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia. Applied Health Economics and Health Policy. 16(4). 495–502. 12 indexed citations

18.

Graaff, Barbara de, et al.. (2016). Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study. Australian Health Review. 41(3). 254–267. 8 indexed citations

19.

Si, Lei, Tania Winzenberg, Barbara de Graaff, & Andrew Palmer. (2014). A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporosis International. 25(8). 1987–97. 77 indexed citations

20.

Patel, Pankaj, Rahul P. Patel, Susan Brandon, et al.. (2012). Effects of Filtration on the Presence of Particulate and Oxycodone Content of Injections Prepared from Crushed OxyContin® Tablets. Current Drug Safety. 7(3). 218–224. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact